A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

ALS is a progressive neurodegenerative disease that currently has no cure. Commonly known as Lou Gehrig’s disease, ALS ...

AI-generated voice clones are bringing back the voices of people with MND, allowing some to communicate, connect, and even ...

Neighborhood disadvantage, or living in a poorer region, was linked to significantly shorter survival time for ALS patients ...

A new UCLA Health study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease ...

Players like Kerry Goode. The pride of Hazelwood High School once dreamed of plunging into the endzone and helping his team ...

Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a Michigan Medicine-led study suggests.

Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a study suggests. Similar studies have shown that ...

In a real-world study, In the end, researchers compared 395 ALS patients who'd been given Radicava against 395 matched controls who hadn't.

Yes, amyotrophic lateral sclerosis (ALS) can cause quadriplegia ... Sometimes, end-of-life care takes place in a hospice, but a person may also receive end-of-life care at home.

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS). Under the leadership of Principal Investigator Prof Merit Cudkowicz, MD, Director of the Sean M. Healey ...